1,755 filings
Page 23 of 88
6-K
4wkb djto
5 Jan 16
Teva Announces Launch of Generic Ortho Tri-cyclen® Lo In the United States
12:00am
6-K
i8r jld2l
4 Jan 16
Teva Announces Exercise of Underwriters’ Over-Allotment Option
12:00am
6-K
8swx856q3qe0
4 Jan 16
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
12:00am
6-K
9uef82lk9pfzqarb6
28 Dec 15
Live Filing
12:00am
6-K
11dndaip
10 Dec 15
FDA Advisory Committee Recommends Approval of Teva’s Asthma Biologic Reslizumab
12:00am
SC 13D
kca0ox84lg9qy2o fp
10 Dec 15
Wave Life Sciences Ltd.
12:00am
6-K
nb9fonzonhklurbspd2b
8 Dec 15
Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKA™ (bendamustine hydrochloride) Injection
12:00am
6-K
34irw ebz
8 Dec 15
Teva Announces Closing of Public Offerings of American Depositary Shares and Mandatory Convertible Preferred
12:00am
6-K
24ob6dx
7 Dec 15
Teva Prevails in European Patent Opposition Hearing on Copaxone 40 mg; Invalidity Challenge Denied
12:00am
424B5
it5nk
3 Dec 15
Prospectus supplement for primary offering
12:00am
6-K
pbet h649qp8a6o
3 Dec 15
Live Filing
12:00am
424B5
hbptmbesi
3 Dec 15
Prospectus supplement for primary offering
12:00am
FWP
dtdz24
3 Dec 15
Free writing prospectus
12:00am
6-K
9k9tg
30 Nov 15
Current report (foreign)
12:00am
F-6EF
uzctum3f jp6uqtpp
30 Nov 15
Automatic registration for ADRs (foreign)
12:00am
F-3ASR
u73jdbksq
30 Nov 15
Automatic shelf registration (foreign)
12:00am
6-K
zrcru2vv5v8oy6icmam
30 Nov 15
Current report (foreign)
12:00am
424B5
58vqoo3 gvcwv6fk
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
bitjragzkefcnqqcnh4
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
bmubcl
30 Nov 15
Current report (foreign)
12:00am